Moreover, the latest study stated that IL-6 might mediate a delirium-like phenotype in the mouse model of UTI, providing a preclinical rationale for clinical studies of IL-6 inhibitors for the treatment of delirium-induced by UTI [34]. This evidence concerns the gene IL6 and bacterial urinary tract infection.